Kantipur Pharmaceuticals Obtains Approval to issue IPO

Nov 05, 2026 02:20 PM Merolagani



Kantipur Pharmaceuticals Lab has obained approval from Securities Board of Nepal (SEBON) to issue initial public offering (IPO). 

 

Following the approval, the company will issue 8 million units of shares worth Rs 800 million at a face value of Rs 100 per unit.

Out of the total offered shares, 1.7 million units i.e. 21.25% have been set aside for the general public. The remaining 6.3 million (78.75%) have been allocated to other groups.

The company has appointed Muktinath Capital Limited as issue manager.